Aclaris Therapeutics Inc (NASDAQ: ACRS) on Monday, soared 9.56% from the previous trading day, before settling in for the closing price of $2.51. Within the past 52 weeks, ACRS’s price has moved between $1.05 and $4.44.
Healthcare Sector giant saw their annual sales surged by 15.24% over the last five years. The company achieved an average annual earnings per share of 68.84%. With a float of $92.51 million, this company’s outstanding shares have now reached $108.34 million.
Aclaris Therapeutics Inc (ACRS) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Aclaris Therapeutics Inc is 14.62%, while institutional ownership is 67.19%.
Aclaris Therapeutics Inc (ACRS) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.01 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.38) by -0.64. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 68.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.01% during the next five years compared to 15.24% growth over the previous five years of trading.
Aclaris Therapeutics Inc (NASDAQ: ACRS) Trading Performance Indicators
Aclaris Therapeutics Inc (ACRS) is currently performing well based on its current performance indicators. A quick ratio of 3.92 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.38, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.60 in one year’s time.
Technical Analysis of Aclaris Therapeutics Inc (ACRS)
Analysing the last 5-days average volume posted by the [Aclaris Therapeutics Inc, ACRS], we can find that recorded value of 1.08 million was better than the volume posted last year of 1.04 million. As of the previous 9 days, the stock’s Stochastic %D was 78.84%.
During the past 100 days, Aclaris Therapeutics Inc’s (ACRS) raw stochastic average was set at 97.77%, which indicates a significant increase from 95.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.24 in the past 14 days, which was higher than the 0.14 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.14, while its 200-day Moving Average is $1.74. Now, the first resistance to watch is $2.87. This is followed by the second major resistance level at $2.98. The third major resistance level sits at $3.19. If the price goes on to break the first support level at $2.55, it is likely to go to the next support level at $2.34. Should the price break the second support level, the third support level stands at $2.23.
Aclaris Therapeutics Inc (NASDAQ: ACRS) Key Stats
Market capitalization of the company is 297.95 million based on 108,345K outstanding shares. Right now, sales total 18,720 K and income totals -132,070 K. The company made 3,300 K in profit during its latest quarter, and -14,610 K in sales during its previous quarter.
